[ Tue, Jan 28th 2025 ]: WOPRAI
[ Tue, Jan 28th 2025 ]: WOPRAI
[ Tue, Jan 28th 2025 ]: WOPRAI
[ Tue, Jan 28th 2025 ]: WOPRAI
[ Tue, Jan 28th 2025 ]: WOPRAI
[ Tue, Jan 28th 2025 ]: WOPRAI
[ Tue, Jan 28th 2025 ]: WOPRAI
[ Tue, Jan 28th 2025 ]: WOPRAI
[ Tue, Jan 28th 2025 ]: WOPRAI
[ Tue, Jan 28th 2025 ]: WOPRAI
[ Tue, Jan 28th 2025 ]: WOPRAI
[ Tue, Jan 28th 2025 ]: NewsNation
[ Tue, Jan 28th 2025 ]: Reuters
[ Tue, Jan 28th 2025 ]: Investing
[ Tue, Jan 28th 2025 ]: MSN
[ Tue, Jan 28th 2025 ]: WOPRAI
[ Tue, Jan 28th 2025 ]: FXStreet
[ Mon, Jan 27th 2025 ]: CoinTelegraph
[ Mon, Jan 27th 2025 ]: MSN
[ Mon, Jan 27th 2025 ]: MSN
[ Mon, Jan 27th 2025 ]: MSN
[ Mon, Jan 27th 2025 ]: MSN
[ Mon, Jan 27th 2025 ]: MSN
[ Mon, Jan 27th 2025 ]: MSN
[ Mon, Jan 27th 2025 ]: MoneyWeek
[ Mon, Jan 27th 2025 ]: MSN
[ Mon, Jan 27th 2025 ]: MSN
[ Mon, Jan 27th 2025 ]: Kiplinger
[ Mon, Jan 27th 2025 ]: Forbes
[ Mon, Jan 27th 2025 ]: MSN
[ Mon, Jan 27th 2025 ]: Investopedia
[ Mon, Jan 27th 2025 ]: MSN
[ Mon, Jan 27th 2025 ]: WOPRAI
[ Mon, Jan 27th 2025 ]: WOPRAI
[ Mon, Jan 27th 2025 ]: WOPRAI
[ Mon, Jan 27th 2025 ]: WOPRAI
[ Mon, Jan 27th 2025 ]: WOPRAI
[ Mon, Jan 27th 2025 ]: WOPRAI
[ Mon, Jan 27th 2025 ]: WOPRAI
[ Mon, Jan 27th 2025 ]: WOPRAI
[ Mon, Jan 27th 2025 ]: WOPRAI
[ Mon, Jan 27th 2025 ]: WOPRAI
[ Mon, Jan 27th 2025 ]: WOPRAI
[ Mon, Jan 27th 2025 ]: WOPRAI
[ Mon, Jan 27th 2025 ]: WOPRAI
[ Mon, Jan 27th 2025 ]: WOPRAI
[ Mon, Jan 27th 2025 ]: WOPRAI
Li Watsek Reiterated (ALXO) at Overweight on, Jan 24th, 2025
- 🞛 This publication is a summary or evaluation of another publication
- 🞛 This publication contains editorial commentary or bias from the source
- 🞛 This publication contains potentially derogatory content such as foul language or violent themes
Li Watsek of Cantor Fitzgerald, Reiterated "ALX Oncology Holdings Inc." (ALXO) at Overweight on, Jan 24th, 2025.
Li has made no other calls on ALXO in the last 4 months.
There is 1 other peer that has a rating on ALXO. Out of the 1 peers that are also analyzing ALXO, all agrees with Li's Rating of Hold. Following is the relevant analyst calls for the last 4 months
- Michael Yee of "Jefferies" Downgraded at Hold and Decreased Target to $2 on, Thursday, December 19th, 2024